October 29, 2021 10:38 AM EDT

Covid-19 roundup: Takeda preps rollout of Novavax shot for next year — report; G20 targets 70% world vaccination rate by mid-2022

Nicole DeFeudis

Editor

Josh Sullivan

A couple days after Novavax filed for authorization of its Covid-19 vaccine in the UK, the company is reportedly plotting a Japanese rollout sometime …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Covid-19 roundup: Takeda preps rollout of Novavax shot for next year — report; G20 targets 70% world vaccination rate by mid-2022

Nicole DeFeudis

Editor

Josh Sullivan

Sign up to read this article for free.

Trump names Johns Hopkins researcher Marty Makary to lead the FDA; also names CDC, Surgeon General picks

FDA approves BridgeBio's heart disease drug, setting up competition with Pfizer, Alnylam

Drug or biologic? An Eli Lilly lawsuit could impact weight loss drug compounders

Lilly's board undergoes more changes; Merck strategy chief joins Roger Perlmutter at Eikon

Surrounded by AI bio giants, tiny startup Nabla Bio makes de novo antibodies look more like drugs

Are programs with compounded GLP-1s safe for your population?

Covid-19 roundup: Take­da preps roll­out of No­vavax shot for next year — re­port; G20 tar­gets 70% world vac­ci­na­tion rate by mid-2022

Editor

Sign up to read this article for free.

Covid-19 roundup: Takeda preps rollout of Novavax shot for next year — report; G20 targets 70% world vaccination rate by mid-2022